New antibody shot against tick virus heads to first human tests
Disease control
Not yet recruiting
This early-stage study tests a new antibody drug called TBE025 in 18 healthy adults aged 18 to 55. The goal is to see if it is safe and how the body processes it when given through a vein. Participants get a single dose and are closely monitored for side effects. This research he…
Phase: PHASE1 • Sponsor: Giuseppe Pantaleo • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC